A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma - Garcia, G; Magnan, A; Chiron, R; Contin-Bordes, C; Berger, P; Taillé, C; Devouassoux, G; de Blay, F; Couderc, L J; Didier, A; O’Callaghan, D S; Girodet, P O; Bourdeix, I; Le Gros, V; Humbert, M (Chest, 2013)